Brief: Medicure FDA approves new Aggrastat product format
01/09/2016 13:00
Sept 1 (Reuters) - Medicure Inc MPH.V
* FDA approves new AGGRASTAT product format
* Commercial release of bolus vial will take place at
beginning of Q4 of this year
Source text for Eikon: ID:nPn3yKVyra
Further company coverage: MPH.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Medicure
See all newsBrief: Medicure Announces Resignation Of Board Member And Grant Of Stock Options
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021